I. Assessment
A. Policy and Research Question
Policy Question:
Should the Philippine government introduce COVID-19 IgG and IgM RDT kits in detecting COVID19 cases among mild and asymptomatic at-risk cases versus no testing?
Research Questions:
- What are the evidence-based guidelines for the use of COVID-19 IgG and IgM RDT kits among mild and asymptomatic at-risk cases? What are the current COVID-19 testing protocols among healthcare systems?
- What is the accuracy of COVID-19 IgG and IgM RDT kits in detecting COVID19 cases among mild and asymptomatic at-risk cases versus gold standard testing?
- Does COVID-19 IgG and IgM RDT kits represent value for money (in terms of cost per additional case detected) in detecting COVID19 among mild and asymptomatic at-risk cases versus no testing?
B. Protocol: Not available.
C. Reviewers: Health Technology Assessment Unit, DOH
D. Start of Review: March 23, 2020
E. End of Review: March 25, 2020
II. Recommendation
Evidence summary: Use of COVID-19 IgG and IgM Rapid Diagnostic Test (RDT) Kits for Mild and Asymptomatic At-Risk COVID-19 Cases
Rapid review: Use of COVID-19 IgG and IgM Rapid Diagnostic Test (RDT) Kits for Mild and Asymptomatic At-Risk COVID-19 Cases
III. Decision
Not available.